Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgPro20 Subcutaneous Immunoglobulin in Primary Immunodeficiency (Japan Phase 3)
jRCT2080221234Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of immune serum globulin in Immunogenetic disorder, hypogammaglobulinemia and agammaglobulinemia, sponsored by CSL Limited. Started Sep 2010; status: completed.
02
Drugs
immune serum globulin
03
Conditions
Immunogenetic disorderhypogammaglobulinemiaagammaglobulinemia
Beyond the preview
Go deeper on jRCT2080221234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221234.